Menu Search
Equities

Klotho Neuroscience Inc

KLTO:NMQ

Klotho Neuroscience Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.35
  • Today's Change-0.04 / -10.26%
  • Shares traded371.55k
  • 1 Year change-96.73%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Klotho Neuroscience Inc fell by 168.42k. However, Cash Flow from Investing totalled 101.91m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.26m for operations while cash used for financing totalled 100.82m.
Cash flow per share-0.0635
Price/Cash flow per share--
Book value per share-0.099
Tangible book value per share-0.2463
More ▼

Balance sheet in USDView more

Klotho Neuroscience Inc has a Debt to Total Capital ratio of 165.64%, a higher figure than the previous year's 1.72%.
Current ratio1.11
Quick ratio--
Total debt/total equity--
Total debt/total capital1.66
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.